Future-Proofing a Volatile Supply Chain Through Modular Biomanufacturing

Biopharmaceutical supply chain volatility is at an all-time high, even as drug companies increase their reliance on outsourcing. To navigate this complexity, contract development and manufacturing organizations (CDMOs) must prioritize robust sourcing strategies and proactive vendor management. The kojoX ecosystem created by FUJIFILM Biotechnologies is transforming biologics development and manufacturing by integrating modularization and standardization, mitigating supply chain risks while enhancing flexibility, scalability, and resilience. Through continuous innovation, strategic investment, and long-term partnerships, kojoX is reshaping the industry, ensuring a more agile and futureproofed biomanufacturing ecosystem.